Why do we have Speaker Compliance Guidelines and Training?



Similar documents
WALKING THE COMPLIANCE LINE: A REGULATORY LAWYER S PERSPECTIVE

Business Conduct Standards for Interactions with Healthcare Professionals. Pocket Guide for U.S. Sales Professionals. Do The Right Thing

Bayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code

U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT

Code of Conduct. Compliance W.I.N.S Worldwide Integrity is Necessary for Success

Amgen GLOBAL CORPORATE COMPLIANCE POLICY

Keeping our Focus: Compliance Summary for Customers and Health Care Professionals. Understanding the Olympus Health Care Compliance Code of Conduct

DUVAL CLIENT ALERT December 2009

Orange Guide (also known as the Field Guide)

Use of Social Media by Pharmaceutical Medical Information Teams

Introduction to Compliance with FDA Labeling and Advertising Requirements

A PASSION FOR INTEGRITY. Every Day Health Care Compliance. Code of Conduct

Physicians Expectations of Industry and Sales Personnel

1 st Tier & Downstream Training Focus

University of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents

Fraud, Waste and Abuse Training

CORPORATE INTEGRITY AGREEMENT

LIBRARY GUIDE: Medical Device Sales & Marketing

Can You Get Insurance Coverage for False Claims Act and Similar Claims? Making Sure You ve Looked at All Possible Avenues of Recovery

PhRMA Code on Interactions with Healthcare Professionals

3. HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION

Is it time for a new drug development paradigm?

Meeting the HIPAA Training and Business Associate Requirements Questions and Answers, with HIPAA Security Expert Mike Semel

Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010

Fraud Waste and Abuse Training Requirement. To Whom It May Concern:

The Chairman s Message on Health Care Compliance

CORNERSTONE THERAPEUTICS INC. SECOND AMENDED AND RESTATED CODE OF BUSINESS CONDUCT AND ETHICS

Upcoming OCR Audits for HIPAA Compliance: How Prepared and Confident are Medical Practices and Billing Companies?

Orange Guide (also known as the Field Guide)

Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy. Introduction

International Transplant Nurses Society Speaker / Planner Bio Form

Mitigating Compliance

INTEGRITY IN ACTION - HEALTH CARE COMPLIANCE

Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training

University of Miami Miller School of Medicine

Understanding the Key Challenges when Entering into a Corporate Integrity Agreement

The Ohio State University Medical Center Vendor Interaction Policy Approved OSUMC Executive Cabinet, March 12, 2009 Policy effective July 1, 2009

LIBRARY GUIDE: Pharmaceutical Sales & Marketing

CME Updates Douglas W. Hanto, M.D., PhD Associate Dean for Continuing Medical Education Professor of Surgery

RE: NDA: DICLEGIS (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets, for oral use MA # 350 WARNING LETTER

MA Healthcare Reform Legislation: Overview of Massachusetts Department of Public Health Regulations

02/2013. Editorial. Mitigating Compliance Risks. Piergiorgio Pepe Antitrust Compliance: The Benefits and Impact

Guidance for Industry Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices

Advertising Compliance Questions and Answers by David Dickinson

How To Accredit A Continuing Education Program

HIPAA Privacy Rule Policies

CMS Mandated Training for Providers, First Tier, Downstream and Related Entities

Faculty of Law Program - Bangalore University (LSS)

Regulatory Affairs Professionals Society: Regulatory Affairs Certification (RAC) Study Group FDA Regulation of Advertising and Promotion

COMPLIANCE Solutions. Risky Business? Haunting Prose In The Line Of Fire. Responsible Executive MEDICAL DEVICE BUTLER SNOW.

Board Statute Regarding Gifts to Physicians

SUPPLEMENTAL NOTE ON SUBSTITUTE FOR SENATE BILL NO. 11

1.3 There have been no material or substantive changes to the Code since last year.

University of Cincinnati College of Medicine

Title: Gifts and Business Courtesies

Charter. Regulatory and Compliance Committee

Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation

MEDICAID AND MEDICARE (PARTS C&D) FRAUD, WASTE AND ABUSE TRAINING

Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011

The following presentation was based on the

Industry Sponsored Satellite Symposia Information and Application

CME Activity Development Guide TABLE OF CONTENTS

Health Policy 201 drugs. Ellen Andrews, PhD Fall 2011

GSK Code of Practice for promotion and customer interactions

A Handbook for Planning Committees Developing Educational Programs

HIGHMARK INC. THIRD PARTY CODE OF BUSINESS CONDUCT

Industry Hosted Events Space Request and Registration Form

GUIDELINES FOR PHYSICIANS IN INTERACTIONS WITH INDUSTRY

A Handbook for Planning Committees Developing Educational Programs

U.S. CORPORATE ETHICS AND COMPLIANCE POLICY

MEDICARE COMPLIANCE TRAINING EMPLOYEES & FDR S Revised

MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations

Behavioral Healthcare, Inc. 155 Inverness Drive West Suite 201 Englewood, CO 80112

Compliance and Program Integrity Melanie Bicigo, CHC, CEBS

Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies

Updated HIPAA Regulations What Optometrists Need to Know Now. HIPAA Overview

GUIDE TO VERMONT S PRESCRIBED PRODUCTS LAW FOR FY10 DISCLOSURES Published by the Vermont Office of the Attorney General 11/5/2009

HIPAA PRIVACY FOR EMPLOYERS A Comprehensive Introduction. HIPAA Privacy Regulations-General

FRAUD, WASTE & ABUSE. Training for First Tier, Downstream and Related Entities. Slide 1 of 24

How to Conduct a Clinical Research Compliance Assessment

Direct Marketing. INSU 2500 Chapter 5 Insurance Occupations. E-Commerce. Insurance Marketing and Distribution

HIPAA Business Associate Contract. Definitions

New Safe Harbors and Stark Exceptions for Electronic Prescribing and Electronic Health Records Arrangements

HSC-NO and Medical Billing

o DOSAGE AND ADMINISTRATION Dosage in Special Populations: The recommended initial dose is 0.5 mg BID in patients who are elderly

Compliance Plan False Claims Act & Whistleblower Provisions Purpose/Policy/Procedures

Comments on the 21 st Century Cures: Digital Health Care

BlueCross BlueShield of Tennessee Senior Care Division and Volunteer State Health Plan

SECTION 18 1 FRAUD, WASTE AND ABUSE

Second Circuit Vacates Off-Label Promotion Conviction on First Amendment Grounds in U.S. v. Caronia

Privacy Space. Public Place. How to Protect PHI and be HIPAA Compliant

MODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING

E-Commerce. INSU 2500 Chapter 5 Insurance Occupations INSURANCE OCCUPATIONS. Direct Marketing AGENT. Insurance Marketing and Distribution

Health Care Compliance Association

Healthcare Law Compliance Guide (commonly known as the White Guide)

Policies and Procedures SECTION:

Medicare Fraud, Waste, and Abuse Training for Healthcare Professionals

Healthcare Law Compliance Guide (commonly known as the White Guide)

MEDICAID AND MEDICARE (PARTS C&D) FRAUD, WASTE AND ABUSE TRAINING

Robert A. Wade, Esq. Krieg DeVault LLP 4101 Edison Lakes Parkway, Ste. 100 Mishawaka, IN Phone: KD_

Transcription:

Disclaimer The views expressed in this presentation are the views of the facilitators and do not necessarily represent the views or policies of our employer.

Why do we have Speaker Compliance Guidelines and Training? Pharmaceutical companies are responsible for activities conducted by or on behalf of that Company Considerations when engaging Speakers/Consultants: Speakers are acting on behalf of your Company Speakers are held to the same regulatory standards as your Company employees Speakers should only use your Company approved slide deck and materials Speakers should have fully executed contract in place with your Company 5

FDA Monitoring The FDA monitors company controlled activities by the pharmaceutical industry, examples include: Including complaints from speaker program attendees regarding inappropriate activities FDA s Bad Ad Program The FDA has cited companies and speakers for violations made by their speakers Such letters are made public on the FDA website http://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/surveillance/drugmarketingadvertisingandcommunications/ucm209384.htm

The Compliance Environment Compliance policies are based on government laws, regulations, industry codes and company guidelines Non-compliance can result in: Industry Fines Corporate Integrity Agreements (CIA) Government exclusion from federal health care programs (Medicare and Medicaid)

Criteria, criteria, criteria What does the selection process look like within your company? Where do speaker recommendations originate? How has Open Payments impacted speaker availability? Expected qualifications well documented? National/Regional/Local designations? Minimum requirements for continued participation?

Example Selection Process Criteria National Faculty Criteria Tier 1 Tier 2 Tier 3 Primary Considerations: -Years since Post Graduate Completion 10+ 5+ 0+ - Professional Organizations (medically related) 5+ 2+ 0+ - Presentations (includes promo, grand rounds, CME, etc.) 20+ 5+ 0+ - Publications (includes articles & abstracts) 20+ 5+ 0+ - Research experiences/trials Yes Yes No Optional Considerations: -Academic Appointments Yes Yes No -Previous Speaker Bureau experience (any company) Yes Yes No Minimum # of Qualifications Met: Minimum Primary Criteria Met 4+ 3+ 2+

Speaker training, what does it look like? Who in your company is responsible for designing, creating and executing Speaker Training? Is there a standardized process? How is it executed? Live, virtual, other? How are you addressing scenarios where speakers cannot attend training? How are they trained to handle: Unsolicited off-label questions? Questions regarding reimbursement? Reports of Adverse Events or Product Quality Complaints? How do you handle speaker requests to modify or add slides? Speaker provides an additional handout to the audience, not company approved

Purpose of Programs GOAL Provide Truthful, Balanced and Accurate information about our company products to Health Care Professionals and Patients Promotional speakers : Remain on-label Provide information that is truthful and not false/misleading Provide fair-balance with product risk/benefit Only use the slide deck approved and provided by the Company Not solicit off-label inquiries

What is Considered Off-Label? Information not consistent with the FDA-approved PI is considered off-label Although physicians may prescribe or use products for off-label uses, the FDA currently prohibits pharmaceutical companies, and consequently any employees or representatives engaged in selling or marketing the Company's products, to promote those unapproved, or off-label uses

Program Watch Outs Promotional Speakers : Proactively discuss off-label use of the product Broaden of product indication Present data out of context Minimize safety issues Omit material information Compare efficacy or safety claims without substantial evidence Overstate efficacy or safety

Employee Training Beyond the standard HCC training, does your company conduct additional training for employees regarding Speaker Programs? What resources or tools do you make available? Does on-the-job training come into play? If so, is it standardized?

Summary: Company Representatives Provide attendees with Package Insert or company approved materials with Package Insert Should not interject while speaker is presenting approved content or solicit speaker to discuss off-label information Address speaker should he or she solicit discussions on off-label information Complete the speaker evaluation Report any non-compliance to manager and Health Care Compliance Officer immediately.

Mitigating Risks What safeguards do you have established regarding compliant speaker programs? Observations what is your process? How are observations allocated? Risk based?? Who conducts observations? How are they trained? Process for scheduling? Heads up vs. show up? Third-Party Vendor what is the scope of their role in this process? Other ways to mitigate risk?